PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 111 filers reported holding PLIANT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,285,884 | +10.9% | 939,209 | +15.9% | 0.58% | +28.3% |
| Q2 2023 | $14,683,669 | +6.4% | 810,357 | +56.1% | 0.45% | +7.6% |
| Q1 2023 | $13,804,469 | +41.4% | 518,965 | +2.7% | 0.42% | +40.5% |
| Q4 2022 | $9,765,207 | +22.7% | 505,184 | +32.6% | 0.30% | +15.0% |
| Q3 2022 | $7,961,000 | +87.6% | 381,093 | -28.1% | 0.26% | +79.3% |
| Q2 2022 | $4,244,000 | +23.7% | 529,811 | +8.3% | 0.14% | +70.6% |
| Q1 2022 | $3,430,000 | -7.0% | 489,334 | +79.1% | 0.08% | +11.8% |
| Q4 2021 | $3,688,000 | – | 273,185 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |